Benzinga - by Lisa Levin, Benzinga Editor.
Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.
Patterson posted adjusted earnings of 50 cents per share, missing market estimates of 58 cents per share. The company’s quarterly sales came in at $1.65 billion versus expectations of $1.70 billion.
Patterson shares declined 14% to $27.01 on Wednesday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares jumped 135.2% to $10.53 after the company received first ever FDA 510(k) clearance for oral device treatment of severe obstructive sleep apnea.
- China Pharma Holdings, Inc. (NYSE: CPHI) climbed 86.7% to $0.1861. China Pharma reported completion of third party testing of dry eye disease therapeutic device.
- Envoy Medical, Inc. (NASDAQ: COCH) shares jumped 55.3% to $2.75. Envoy Medical, last week, reported a profit for the third quarter.
- Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 49.4% to $0.2841. Avenue Therapeutics recently posted a profit for the third quarter.
- Biomea Fusion, Inc. (NASDAQ: BMEA) shares jumped 40.1% to $13.93.
- Yoshiharu Global Co. (NASDAQ: YOSH) shares gained 33.4% to $6.39 after gaining over 22% on Tuesday.
- 10X Capital Venture Acquisition Corp. II (NASDAQ: VCXA) surged 30.3% to $10.61.
- Rover Group, Inc. (NASDAQ: ROVR) gained 28.4% to $10.93 after the company announced it agreed to be acquired by Blackstone in a $2.3 billion transaction.
- Fluence Energy, Inc. (NASDAQ: FLNC) shares jumped 28% to $25.95 after reporting fourth-quarter results. Fluence Energy also initiated FY24 revenue guidance of $2.7 billion to $3.3 billion.
- Ault Alliance, Inc. (NYSE: AULT) shares gained 25.6% to $0.1020. Ault Alliance announced its intention to commence an exchange offer to acquire shares of its common stock for up to $15 million in Series D preferred shares.
- RedHill Biopharma Ltd. (NASDAQ: RDHL) shares gained 24.3% to $2.8398 after jumping 128% on Tuesday. Redhill Biopharma recently announced the FDA has granted five years' market exclusivity for Talicia.
- Conduit Pharmaceuticals Inc. (NASDAQ: CDT) climbed 21.5% to $3.5851.
- Foot Locker, Inc. (NYSE: FL) surged 18% to $28.13 after the company reported better-than-expected third-quarter financial results.
- QuantumScape Corporation (NYSE: QS) climbed 17% to $6.70.
- GameStop Corp. (NYSE: GME) gained 16.3% to $15.70 after gaining around 13% on Tuesday.
- NetApp, Inc. (NASDAQ: NTAP) gained 14.4% to $89.42 after the company reported better-than-expected second-quarter financial results and issued FY24 EPS guidance above estimates.
- Carvana Co. (NYSE: CVNA) rose 12% to $35.40. Carvana expanded same day delivery offering to Central Florida
- residents.
- vTv Therapeutics Inc. (NASDAQ: VTVT) surged 11.2% to $10.61. vTv Therapeutics recently announced a 1-for-40 reverse stock split.
- Workday, Inc. (NASDAQ: WDAY) gained 8.5% to $257.42 after the company reported upbeat earnings results for its third quarter.
- Hewlett Packard Enterprise Company (NYSE: HPE) climbed 8.5% to $16.84 following upbeat earnings.
- Genesco Inc. (NYSE: GCO) climbed 7.9% to $34.88.
- CrowdStrike Holdings, Inc. (NASDAQ: CRWD) gained 7.5% to $228.08 as the company posted better-than-expected earnings for its third quarter.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- BioVie Inc. (NASDAQ: BIVI) shares dipped 62.4% to $1.8766 after the company announced topline efficacy data from its Phase 3 trial of NE3107 for mild to moderate Alzheimer's disease.
- Treasure Global Inc. (NASDAQ: TGL) fell 47.5% to $0.1081 after the company reported pricing of $4 million underwritten public offering.
- Farfetch Limited (NYSE: FTCH) fell 43.1% to $1.1943. Farfetch said it will not announce its third quarter financial results and will not hold its related conference call earlier scheduled for Nov. 29, 2023.
- Seelos Therapeutics, Inc. (NASDAQ: SEEL) fell 39.4% to $1.4380 after the company reported pricing of $5.55 million public offering.
- BiomX Inc. (NYSE: PHGE) fell 32.1% to $0.38. BiomX announced safety and efficacy results from Part 2 of the Phase 1B/2A trial of BX004 for chronic pulmonary infections due to pseudomonas aeruginosa in cystic fibrosis patients, showing clinically meaningful improvement in pulmonary function.
- Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) fell 23.6% to $2.93 after the company reported worse-than-expected third-quarter financial results and lowered FY23 adjusted EPS guidance below estimates.
- Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) declined 22.2% to $6.40 after the company announced management change
- Leslie's, Inc. (NASDAQ: LESL) shares fell 21.5% to $4.56 after the company reported mixed fourth-quarter financial results.
- Journey Medical Corporation (NASDAQ: DERM) declined 20% to $4.34.
- CoreCard Corporation (NYSE: CCRD) declined 16.6% to $13.02 after the company reported a year-over-year decrease in third-quarter EPS results and worse-than-expected revenue results.
- HNR Acquisition Corp (NASDAQ: HNRA) fell 14.3% to $3.12. HNR Acquisition shares jumped 110% on Tuesday after the company gave a business update.
- ESGL Holdings Limited (NASDAQ: ESGL) fell 13.1% to $1.13 after jumping 45% on Tuesday. ESGL recently announced a multi-year contract renewal with Singapore Refining Company Private Limited.
- Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) shares fell 12.6% to $3.6250. Biodexa Pharmaceuticals shares fell over 18% on Tuesday after the company announced an offering of 1,397,849 Class A units at an assumed public offering price of $2.79 per Class A unit.
- Jabil Inc. (NYSE: JBL) fell 11.6% to $115.47 after the company updated first quarter, second quarter and FY24 revenue guidance below estimates.
- Bilibili Inc. (NASDAQ: BILI) dipped 8.2% to $12.25. Bilibili reported third-quarter FY23 revenue of $795.7 million (RMB5.8 billion), flat year-on-year, missing the consensus of $817.3 million.
- Okta, Inc. (NASDAQ: OKTA) shares declined 4.4% to $69.40 following third-quarter results.
- Verve Therapeutics, Inc. (NASDAQ: VERV) shares fell 4% to $11.46 after the company reported pricing of public offering of common stock and concurrent private placement.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Salesforce Gears Up For Q3 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.